| Models Name |
Cat.No. |
Animal Type |
Disease Area |
|
Psoriasis, imiquimod-induced, in mouse (C57BL/6J)
|
AB80837 |
mouse |
Psoriasis |
|
Psoriasis, imiquimod/denervation-induced, in mouse (C57BL/6J)
|
AB80838 |
mouse |
Psoriasis |
|
Psoriasis, Mir210 knockout/imiquimod-induced, in mouse (C57BL/6J)
|
AB80839 |
mouse |
Psoriasis |
|
Psoriasis, murine recombinant IL-23-induced, in mouse (C57BL/6J)
|
AB80840 |
mouse |
Psoriasis |
|
Psychiatric disorders, acute restraint stress-induced, in mouse (C57BL/6J)
|
AB80841 |
mouse |
Psychiatric Disorders |
|
Psychosis, cocaine-induced, in mouse (C57BL/6J)
|
AB80842 |
mouse |
Psychosis |
|
Pulmonary arterial hypertension, Eya3 mutated/semaxanib/hypoxia-induced, in mouse (C57BL/6J)
|
AB80843 |
mouse |
Hypertension,pulmonary arterial |
|
Pulmonary arterial hypertension, hypoxia-induced, in mouse (C57BL/6J)
|
AB80844 |
mouse |
Hypertension,pulmonary arterial |
|
Pulmonary arterial hypertension, pristane-induced, in mouse (C57BL/6J)
|
AB80845 |
mouse |
Hypertension,pulmonary arterial |
|
Pulmonary arterial hypertension, pristane/chronic hypoxia-induced, in mouse (C57BL/6J)
|
AB80846 |
mouse |
Hypertension,pulmonary arterial |